Daniel A. Camardo's most recent trade in Athersys Inc was a trade of 19,993 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on Oct. 4, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Athersys Inc | Daniel Camardo A. | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. | 04 Oct 2023 | 19,993 | 285,341 (0%) | 0% | 0.4 | 8,797 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.91 per share. | 05 Jul 2023 | 19,993 | 305,334 (0%) | 0% | 0.9 | 18,274 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 04 Apr 2023 | 19,993 | 325,327 (0%) | 0% | 1 | 19,993 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 04 Jan 2023 | 23,484 | 345,320 (0%) | 0% | 0.8 | 19,961 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 22 Nov 2022 | 100,000 | 368,804 (0%) | 0% | 0.5 | 54,960 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2022 | 263,492 | 268,804 (0%) | 0% | 0 | Common Stock | |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.77 per share. | 17 Mar 2022 | 132,800 | 132,800 (0%) | 0% | 0.8 | 102,256 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 4,000,000 | 4,000,000 | - | - | Stock Option (right to purchase) | |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.52 per share. | 05 Apr 2021 | 15,467 | 50,672 (0%) | 0% | 25.5 | 394,718 | Ordinary shares |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 15,467 | 4,333 | - | - | Employee stock option (right to buy) | |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 2,305 | 0 | - | - | Employee stock option (right to buy) | |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.19 per share. | 05 Apr 2021 | 2,305 | 35,205 (0%) | 0% | 17.2 | 39,623 | Ordinary shares |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 509 | 3,441 | - | - | Employee stock option (right to buy) | |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.23 per share. | 05 Apr 2021 | 509 | 51,181 (0%) | 0% | 15.2 | 7,752 | Ordinary shares |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Sale of securities on an exchange or to another person at price $ 84.97 per share. | 30 Mar 2021 | 4,594 | 39,403 (0%) | 0% | 85.0 | 390,352 | Ordinary Shares |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Sale of securities on an exchange or to another person at price $ 86.87 per share. | 30 Mar 2021 | 3,517 | 32,900 (0%) | 0% | 86.9 | 305,522 | Ordinary Shares |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Sale of securities on an exchange or to another person at price $ 85.88 per share. | 30 Mar 2021 | 2,986 | 36,417 (0%) | 0% | 85.9 | 256,438 | Ordinary Shares |
| Horizon Therapeutics Plc | Daniel A. Camardo | EVP and President, U.S. | Sale of securities on an exchange or to another person at price $ 83.58 per share. | 30 Mar 2021 | 1,803 | 43,997 (0%) | 0% | 83.6 | 150,695 | Ordinary Shares |